Karen H. Antman, MD
Provost
Boston University Medical Campus

MD, Columbia University College of Physicians and Surgeons



Dr. Karen Antman, an internationally recognized expert on breast cancer, mesotheliomas and sarcomas, is Provost of the Medical Campus and Dean of Boston University School of Medicine since 2005. Dr. Antman previously served as Deputy Director for Translational and Clinical Sciences at the National Cancer Institute of the National Institutes of Health (NIH) (2004-5) and before that as Wu Professor of Medicine and Pharmacology and Director of the Herbert Irving Comprehensive Cancer Center at Columbia University College of Physicians and Surgeons, where she also co-directed the cancer care service line at New York Presbyterian Hospital. Dr. Antman was voted 1993 Senior Faculty Teacher of the Year by medical residents. She also served on the faculty of Harvard Medical School from 1979 to 1993, and had hospital appointments at Brigham and Women’s Hospital and Dana-Farber Cancer Institute in Boston.

Based on her group’s translational research, Dr Antman developed now standard regimens for the treatment of sarcomas and mesotheliomas as well as regimens for breast cancer and supportive care of patients receiving chemotherapy including pharmacology, growth factors and mobilization of peripheral blood derived stem cells for blood and marrow transplant. Dr. Antman also is outspoken on public health policy issues. She has written extensively about impediments to clinical research on cancer, and she has testified before Congress on the need for federal research dollars to support cancer research with articles in the medical literature (as well as Vogue and Readers Digest). She has written more than 300 journal papers and edited five textbooks and monographs, many with multiple editions.

She is a member of PBK and the Institute of Medicine. She has served as President of the American Society of Clinical Oncology in 1994-5, the American Society of Blood and Marrow Transplant in 1996-7, and the American Association for Cancer Research in 2003-4.

She has more than 300 publications and is the editor of 5 textbooks and monographs (Asbestos related malignancies, Sarcomas of Bone and Soft Tissue, High-dose cancer therapy: pharmacology, hematopoietins and stem cells (3 editions), and Molecular Targeting in Oncology).

She serves on the Administration Board of the American Association of Medical Colleges Council of Deans, the Journal of the American Medical Association Oversight Committee, the International Editorial Board of Lancet, and on the board of the Educational Commission for Foreign Medical Graduates (ECFMG). She has served as an associate editor of the New England Journal of Medicine, and on the Council of the National Institutes of Health’s Fogarty International Center.

She has published reviews and editorials on medical policy and the impact of research funding and managed care on American clinical research and testified before congressional subcommittees on eight occasions on National Institutes of Health (NIH) appropriations and medical policy.

Dean of School of Medicine
Boston University School of Medicine


Professor
Boston University School of Medicine
Medicine
Hematology & Medical Oncology Section

Graduate Faculty (Primary Mentor of Grad Students)
Boston University School of Medicine, Division of Graduate Medical Sciences



2011 Institute of Medicine: Member
2008 American Society of Clinical Oncology : Distinguished Service Award for Scientific Leadership
2001 American Association of Professors: Member
1997 American Association for the Advancement of Science: Elected to Fellowship
1994 Voted by Medical Residents, Columbia-Presbyterian Medical Center: Senior Faculty Teacher of the Year
Phi Beta Kappa: Member





Yr Title Project-Sub Proj Pubs
2008 General Clinical Research Center 5M01RR000533-40 429
2007 General Clinical Research Center 2M01RR000533-39 429
2006 GENERAL CLINICAL RESEARCH CENTER 5M01RR000533-38 429
2005 GENERAL CLINICAL RESEARCH CENTER 5M01RR000533-37 429
2002 CORE--CLINICAL TRIALS CORE FACILITY 5P30CA013696-30-9035 181
2002 CORE--CLINICAL TRIALS CORE FACILITY 3P30CA013696-30S2-9035 181
2002 CORE--CLINICAL TRIALS CORE FACILITY 3P30CA013696-30S1-9035 181
2002 CORE--CLINICAL TRIALS CORE FACILITY 3P30CA013696-29S2-9035 181
2002 COLUMBIA UNIVERSITY SOUTHWEST ONCOLOGY GROUP PROGRAM 5U10CA068183-08 64
2002 CANCER CENTER SUPPORT GRANT 3P30CA013696-30S2 181
Showing 10 of 49 results. Show All Results
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Bharel M, Antman K, Berman H, Dimitri D, Flier J, Flotte T. In Reply to Manion and Khan. Acad Med. 2017 Jun; 92(6):725-726.View Related Profiles. PMID: 28557909.
  2. Antman KH, Berman HA, Flotte TR, Flier J, Dimitri DM, Bharel M. Developing Core Competencies for the Prevention and Management of Prescription Drug Misuse: A Medical Education Collaboration in Massachusetts. Acad Med. 2016 Oct; 91(10):1348-1351.View Related Profiles. PMID: 27532868.
  3. Tefferi A, Kantarjian H, Rajkumar SV, Baker LH, Abkowitz JL, Adamson JW, Advani RH, Allison J, Antman KH, Bast RC, Bennett JM, Benz EJ, Berliner N, Bertino J, Bhatia R, Bhatia S, Bhojwani D, Blanke CD, Bloomfield CD, Bosserman L, Broxmeyer HE, Byrd JC, Cabanillas F, Canellos GP, Chabner BA, Chanan-Khan A, Cheson B, Clarkson B, Cohn SL, Colon-Otero G, Cortes J, Coutre S, Cristofanilli M, Curran WJ, Daley GQ, DeAngelo DJ, Deeg HJ, Einhorn LH, Erba HP, Esteva FJ, Estey E, Fidler IJ, Foran J, Forman S, Freireich E, Fuchs C, George JN, Gertz MA, Giralt S, Golomb H, Greenberg P, Gutterman J, Handin RI, Hellman S, Hoff PM, Hoffman R, Hong WK, Horowitz M, Hortobagyi GN, Hudis C, Issa JP, Johnson BE, Kantoff PW, Kaushansky K, Khayat D, Khuri FR, Kipps TJ, Kripke M, Kyle RA, Larson RA, Lawrence TS, Levine R, Link MP, Lippman SM, Lonial S, Lyman GH, Markman M, Mendelsohn J, Meropol NJ, Messinger Y, Mulvey TM, O''Brien S, Perez-Soler R, Pollock R, Prchal J, Press O, Radich J, Rai K, Rosenberg SA, Rowe JM, Rugo H, Runowicz CD, Sandmaier BM, Saven A, Schafer AI, Schiffer C, Sekeres MA, Silver RT, Siu LL, Steensma DP, Stewart FM, Stock W, Stone R, Storb R, Strong LC, Tallman MS, Thompson M, Ueno NT, Van Etten RA, Vose JM, Wiernik PH, Winer EP, Younes A, Zelenetz AD, LeMaistre CA. In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. Mayo Clin Proc. 2015 Aug; 90(8):996-1000. PMID: 26211600; DOI: 10.1016/j.mayocp.2015.06.001;.
  4. Levine AS, Alpern RJ, Andrews NC, Antman K, Balser JR, Berg JM, Davis PB, Fitz JG, Golden RN, Goldman L, Jameson JL, Lee VS, Polonsky KS, Rappley MD, Reece EA, Rothman PB, Schwinn DA, Shapiro LJ, Spiegel AM. Research in academic medical centers: two threats to sustainable support. Sci Transl Med. 2015 May 27; 7(289):289fs22. PMID: 26019216; DOI: 10.1126/scitranslmed.aac5200;.
  5. Stiff PJ, Agovi MA, Antman KH, Blaise D, Camitta BM, Cairo MS, Childs RW, Edwards JR, Gale RP, Hale GA, Lazarus HM, Arora M. High-dose chemotherapy with blood or bone marrow transplants for rhabdomyosarcoma. Biol Blood Marrow Transplant. 2010 Apr; 16(4):525-32. PMID: 19961947; PMCID: PMC2838953; DOI: 10.1016/j.bbmt.2009.11.020;.
  6. Chabot JA, Tsai WY, Fine RL, Chen C, Kumah CK, Antman KA, Grann VR. Pancreatic proteolytic enzyme therapy compared with gemcitabine-based chemotherapy for the treatment of pancreatic cancer. J Clin Oncol. 2010 Apr 20; 28(12):2058-63. PMID: 19687327; PMCID: PMC2860407; DOI: 10.1200/JCO.2009.22.8429;.
  7. Duley L, Antman K, Arena J, Avezum A, Blumenthal M, Bosch J, Chrolavicius S, Li T, Ounpuu S, Perez AC, Sleight P, Svard R, Temple R, Tsouderous Y, Yunis C, Yusuf S. Specific barriers to the conduct of randomized trials. Clin Trials. 2008; 5(1):40-8. PMID: 18283079; DOI: 10.1177/1740774507087704;.
  8. Murabito JM, Rosenberg CL, Finger D, Kreger BE, Levy D, Splansky GL, Antman K, Hwang SJ. A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study. BMC Med Genet. 2007; 8 Suppl 1:S6.View Related Profiles. PMID: 17903305; PMCID: PMC1995609.
  9. Hassan R, Alexander R, Antman K, Boffetta P, Churg A, Coit D, Hausner P, Kennedy R, Kindler H, Metintas M, Mutti L, Onda M, Pass H, Premkumar A, Roggli V, Sterman D, Sugarbaker P, Taub R, Verschraegen C. Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference. Ann Oncol. 2006 Nov; 17(11):1615-9. PMID: 16600983.
  10. Antman K, Hassan R, Eisner M, Ries LA, Edwards BK. Update on malignant mesothelioma. Oncology (Williston Park). 2005 Sep; 19(10):1301-9; discussion 1309-10, 1313-6. PMID: 16285225.
Showing 10 of 197 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 196 publications over 33 distinct years, with a maximum of 17 publications in 1989

YearPublications
19804
19812
19826
19834
19846
19855
19869
19876
198814
198917
199010
19918
199210
199315
19945
19955
19964
199712
19988
199912
20005
20019
20026
20033
20041
20051
20061
20071
20081
20092
20152
20161
20171
Contact for Mentoring:


72 E. Concord St Instructional (L)
Boston MA 02118
Google Map


Antman's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department